Half Dose of Prasugrel and Ticagrelor in Acute Coronary Syndrome (HOPE-TAILOR)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.
Also called NCT02944123
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 120 participants
- Sponsor
- Registry
-
NCT02944123
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT02944123. Randomized; single masking; primary purpose treatment. Start 2016-09 (actual); primary completion 2020-02 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Half Dose of Prasugrel and Ticagrelor in Acute Coronary Syndrome (HOPE-TAILOR)
- Condition
- Acute Coronary Syndrome
- Intervention (Drug)
- Clopidogrel 75 mg
- Intervention (Drug)
- Prasugrel 5 mg
- Intervention (Drug)
- Ticagrelor 45 mg
- Lead sponsor
- Dong-A University
Record details
- Record id
cardio:ct-nct02944123- Content hash
a1ec019b9954eee9796102e28e03ceb85f58a98868549500b2a3811b394de9ff